4.8 Article

Highly specific antibodies determine histone acetylation site usage in yeast heterochromatin and euchromatin

Journal

MOLECULAR CELL
Volume 8, Issue 2, Pages 473-479

Publisher

CELL PRESS
DOI: 10.1016/S1097-2765(01)00301-X

Keywords

-

Funding

  1. NIGMS NIH HHS [GM23674, GM42421] Funding Source: Medline

Ask authors/readers for more resources

We have developed a highly specific antibody set for acetylation sites in yeast histones H4 (K5, K8, K12, and K16); H3 (K9, K14, K18, K23, and K27); H2A (K7); and H213 (K1I and K16). Since ELISA does not assure antibody specificity in chromatin immunoprecipitation, we have employed additional screens against the respective histone mutations. We now show that telomeric and silent mating locus heterochromatin is hypoacetylated at all histone sites. At the INO1 promoter, RPD3 is required for strongly deacetylating all sites except H4 K16, ESA1 for acetylating H2A, H2B, and H4 sites except H4 K16, and GCN5 for acetylating H213 and H3 sites except H3 K14. These data uncover the in vivo usage of acetylation sites in heterochromatin and euchromatin.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available